Dear Investor, 

Vincent Medical Holdings Limited (1612.HK), a Hong Kong-headquartered medical device manufacturing group, cordially invites you to join its Hong Kong post-result roadshow on 3rd October (Wednesday) to discuss its 2018 interim results, current operations and future strategies. Details are as followed:

You will be meeting with:
  • Mr. Otto TO, CEO / Executive Director
  • Mr. Latrell LAI, Financial Controller 
  • Ms. Katie Tsui, Corporate Development & Investor Relations Manager

Available timeslots (meetings will be conducted in Cantonese/Mandarin/English):

 Date

Time

Meeting

 Wednesday,
3rd October 2018 

 10:00AM – 11:00AM 

  1-on-1 Meeting(Central)

 11:30AM – 12:30AM 

  1-on-1 Meeting(Central)

 02:00PM – 03:00PM 

 Small Group Meeting(Central)
03:30PM – 04:30PM Small Group Meeting(Central)
05:00PM – 06:00PM   1-on-1 Meeting(Central)

Interim Results Highlights:
  • Revenue for 1H2018 increased by 10.6% to HK$227.1 million 
  • Gross profit for 1H2018 increased by 2.7% to HK$72.8 million 
  • Profit attributable to owners of the Company for 1H2018 increased by 4.4% to HK$12.9 million 
  • Basic earnings per share of the Company for 1H2018 increased by 4.1% to HK2.02 cents

About Vincent Medical: 
  • A Hong Kong-headquartered medical device group which develops, manufactures and sells a wide range of medical devices 
  • The second largest exporter of respiratory and anaesthesia disposables in the PRC based on export value in 2015 
  • Focuses on respiratory products, imaging contrast media power injector disposable products, and orthopaedic and rehabilitation products which satisfy internationally-recognised quality assurance standards 
  • Established OEM business since inception, and OBM business in 2003 under the “Inspired Medical” (「英仕醫療」) brand 
  • Strong domestic and overseas distributorship network for its OBM business, with over 400 distributors in the PRC and 70 distributors overseas
<Please kindly reply this email indicating your preferred timeslot(s) or contact Ms. Vivian Li or Mr. Max Lau at +852 2857 7101 for meeting arrangements>  

Best regards,
 
DLK Advisory Limited 金通策略有限公司 | www.dlkadvisory.com
Hong Kong Office:
Room 906, 9/F, Nan Fung Tower, 88 Connaught Road Central, Hong Kong 香港中環干諾道中88號南豐大廈9樓906室
T: +852 2857 7101  |  F: +852 2857 7103

Taiwan Office:
Room 1736, 17/F., No. 270, Sec. 4, Zhongxiao E. Rd., Da-an Dist., Taipei, Taiwan臺北市大安區忠孝東路四段270號17樓1736室
T:+886 2 7707 0616

The information in this email and any attachment(s) is confidential and intended solely for the use of the individual to whom it is addressed. Any unauthorized use or dissemination is prohibited. If you are not the intended recipient, please notify the sender immediately and delete it from your system. E-mail transmission cannot be guaranteed to be secure or error-free. DLK Advisory Limited does not accept liability for any errors or omissions in the information of this email or any attachment(s).
If you do not want to receive this news alert, please click here to unsubscribe.